CPC A61K 41/0052 (2013.01) [A61K 33/06 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); A61K 38/40 (2013.01); A61K 45/06 (2013.01); A61N 5/02 (2013.01); A61N 5/062 (2013.01); A61N 2005/0659 (2013.01); A61N 2005/0661 (2013.01); A61N 2005/0662 (2013.01); A61N 2005/1098 (2013.01)] | 4 Claims |
1. A method of treating an animal subject with cancer, consisting of:
(a) administering a composition to the animal subject,
wherein the composition consists of
(i) a sensitizer which is a metal ion-carbohydrate complex in which (i-a) a metal ion selected from the group consisting of an iron ion and a magnesium ion is noncovalently bound to (i-b) a carbohydrate selected from the group consisting of carboxymaltose, isomaltoside, and starch; and
(ii) water as a pharmaceutically acceptable carrier, and
wherein the administering the composition results in localization of the metal ion of the metal-carbonhydrate complex in a cancerous tissue of the animal; and
(b) applying electromagnetic waves to the animal subject thereby generating amplified heat at cancerous tissue compared to non-cancerous tissues,
wherein the applying electromagnetic waves causes a decrease in a size of cancerous mass of the cancerous tissue.
|